Evidence map›Paper›PMID 21639869›Full record

ArticleMolecular pain2011

Central nervous system mast cells in peripheral inflammatory nociception.

Dimitris N Xanthos, Simon Gaderer, Ruth Drdla, Erin Nuro, Anastasia Abramova, Wilfried Ellmeier, Jürgen Sandkühler

Open access · goldAbstract read
In one paragraph

Article in Molecular pain, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. UltramicronizedBiomolecules · 2023
    Article
  4. GABAergic CaMKIIα+ Amygdala Output Attenuates Pain and Modulates Emotional-Motivational Behavior via Parabrachial Inhibition.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  5. Mast cell-deficient miceSkin health and disease · 2022
    Article
  6. Article
  7. Review
  8. Involvement of Mast Cells in the Pathophysiology of Pain.Frontiers in cellular neuroscience · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Mast Cells in Neurodegenerative Disease.Frontiers in cellular neuroscience · 2019
    Article
  14. Mast Cell Neural Interactions in Health and Disease.Frontiers in cellular neuroscience · 2019
    Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dimitris N XanthosDepartment of Neurophysiology, Center for Brain Research, Medical University of Vienna, Spitalgasse 4, 1090 Vienna, Austria. juergen.sandkuehler@meduniwien.ac.at.
Simon Gaderer
Ruth Drdla
Erin Nuro
Anastasia Abramova
Wilfried Ellmeier
Jürgen Sandkühler
Medical University of Vienna · AT

Funding

Austrian Science Fund FWF P 19930Austrian Science Fund FWF P 22306
6 · The paper itself

Abstract

backgroundFunctional aspects of mast cell-neuronal interactions remain poorly understood. Mast cell activation and degranulation can result in the release of powerful pro-inflammatory mediators such as histamine and cytokines. Cerebral dural mast cells have been proposed to modulate meningeal nociceptor activity and be involved in migraine pathophysiology. Little is known about the functional role of spinal cord dural mast cells. In this study, we examine their potential involvement in nociception and synaptic plasticity in superficial spinal dorsal horn. Changes of lower spinal cord dura mast cells and their contribution to hyperalgesia are examined in animal models of peripheral neurogenic and non-neurogenic inflammation.

resultsSpinal application of supernatant from activated cultured mast cells induces significant mechanical hyperalgesia and long-term potentiation (LTP) at spinal synapses of C-fibers. Lumbar, thoracic and thalamic preparations are then examined for mast cell number and degranulation status after intraplantar capsaicin and carrageenan. Intradermal capsaicin induces a significant percent increase of lumbar dural mast cells at 3 hours post-administration. Peripheral carrageenan in female rats significantly increases mast cell density in the lumbar dura, but not in thoracic dura or thalamus. Intrathecal administration of the mast cell stabilizer sodium cromoglycate or the spleen tyrosine kinase (Syk) inhibitor BAY-613606 reduce the increased percent degranulation and degranulated cell density of lumbar dural mast cells after capsaicin and carrageenan respectively, without affecting hyperalgesia.

conclusionThe results suggest that lumbar dural mast cells may be sufficient but are not necessary for capsaicin or carrageenan-induced hyperalgesia.

Indexed as

AnimalsCapsaicinCarrageenanCell CountCell DegranulationCentral Nervous SystemFemaleHyperalgesiaLong-Term PotentiationLumbar VertebraeMaleMast CellsNerve Fibers, UnmyelinatedNeurogenic InflammationNociceptorsRatsCapsaicinCarrageenan

Identifiers

PMID21639869
PMCPMC3123586
OpenAlexW2096189657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.